Complete Filing Data
MOLINA HEALTHCARE, INC. reported Net Income Loss of $472.00 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MOLINA HEALTHCARE, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $472.0M | $1.18B | $1.09B | $792.0M | $659.0M | $673.0M | $737.0M | $707.0M | -$512.0M | $52.0M | $143.0M | $62.0M | $53.0M | $9.8M | $20.8M | $55.0M |
| Operating Income Loss | $781.0M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | -$555.0M | $306.0M | $387.0M | $193.0M | $137.0M | $41.1M | $135.8M | $105.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $72.0M | $25.0M | $78.0M | -$155.0M | -$42.0M | $33.0M | $12.0M | -$2.0M | -$3.0M | $2.0M | -$3.0M | $0.00 | -$1.0M | $948.0K | $787.0K | -$380.0K |
| Revenues | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | $6.59B | $5.91B | $4.54B | $4.09B |
| Income Tax Expense Benefit | $117.0M | $410.0M | $373.0M | $271.0M | $216.0M | $288.0M | $235.0M | $292.0M | -$100.0M | $153.0M | $179.0M | $73.0M | $36.0M | $10.5M | $42.9M | $34.5M |
| General And Administrative Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765.0M | $666.0M | $518.6M | $393.5M | $346.0M |
| Comprehensive Income Net Of Tax | $544.0M | $1.20B | $1.17B | $637.0M | $617.0M | $706.0M | $749.0M | $705.0M | -$515.0M | $54.0M | $140.0M | $62.0M | $52.0M | $10.7M | $21.6M | $54.6M |
| Interest Expense | $109.0M | $110.0M | $120.0M | $102.0M | $87.0M | $115.0M | $118.0M | $101.0M | $66.0M | $57.0M | $52.0M | $16.8M | $15.5M | $15.5M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $95.0M | $33.0M | $102.0M | -$204.0M | -$55.0M | $44.0M | $16.0M | -$3.0M | -$5.0M | $3.0M | -$5.0M | $0.00 | -$1.0M | $1.5M | $1.2M | -$613.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $23.0M | $8.0M | $24.0M | -$49.0M | -$13.0M | $11.0M | $4.0M | -$1.0M | -$2.0M | $1.0M | -$2.0M | $0.00 | $0.00 | |||
| Health Care Organization Premium Tax Revenue | $1.86B | $1.49B | $1.07B | $873.0M | $787.0M | $649.0M | $489.0M | $417.0M | $438.0M | $468.0M | $397.0M | $294.0M | $172.0M | $159.0M | $154.6M | |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $961.0M | $972.0M | $999.0M | -$612.0M | $205.0M | $322.0M | $135.0M | $81.0M | $23.4M | $120.3M | $89.5M | |||||
| Health Care Organization Premium Revenue | $18.85B | $16.45B | $13.26B | $9.02B | $6.18B | $5.54B | $4.21B | $3.99B | ||||||||
| Technology Services Revenue | $521.0M | $539.0M | $253.0M | $210.0M | $205.0M | $187.7M | $160.4M | $89.8M | ||||||||
| Nonoperating Income Expense | -$109.0M | -$110.0M | -$145.0M | -$117.0M | -$72.0M | -$132.0M | -$57.0M | -$101.0M | -$65.0M | -$58.0M | -$56.0M | |||||
| Other Nonoperating Income Expense | $0.00 | $0.00 | -$25.0M | -$15.0M | $15.0M | -$17.0M | $61.0M | $0.00 | $1.0M | -$1.0M | -$4.0M | -$17.7M | -$15.5M | -$15.5M | ||
| Health Care Organization Insurer Fee Revenue | $0.00 | $0.00 | $271.0M | $0.00 | $329.0M | $0.00 | $292.0M | $244.0M | $120.0M | $0.00 | $0.00 | |||||
| Cost Of Goods And Services Sold | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.91B | |||||||||
| Income Loss From Continuing Operations Per Diluted Share | $0.92 | $2.58 | $1.30 | $0.96 | $0.27 | $1.67 | ||||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.93 | $2.75 | $1.34 | $0.98 | $0.28 | $1.69 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $79.0M | $255.0M | $298.0M | $326.0M | $301.0M | $301.0M | $245.0M | $309.0M | $321.0M | $230.0M | $248.0M | $258.0M | $143.0M | $185.0M | $228.0M | $185.0M | $276.0M | $178.0M | $168.0M | $175.0M | $196.0M | $198.0M | $201.0M | $197.0M | $202.0M | $107.0M | -$262.0M | -$97.0M | -$230.0M | $77.0M | -$47.0M | $42.0M | $33.0M | $24.0M | $30.0M | $46.0M | $39.0M | $28.0M | $34.0M | $16.0M | $8.0M | $4.0M | -$9.1M | $7.6M | $24.6M | $29.9M | $25.6M | $3.4M | -$37.3M | $18.1M | -$33.0M | $19.0M | $17.4M | $17.4M | $16.2M | $10.6M |
| Operating Income Loss | $137.0M | $373.0M | $433.0M | $467.0M | $434.0M | $426.0M | $359.0M | $443.0M | $455.0M | $335.0M | $361.0M | $372.0M | $221.0M | $273.0M | $335.0M | $289.0M | $424.0M | $274.0M | $257.0M | $265.0M | $280.0M | $295.0M | $342.0M | $222.0M | -$81.0M | -$287.0M | $82.0M | -$6.0M | $118.0M | $105.0M | $89.0M | $76.0M | $113.0M | $116.0M | $82.0M | $97.0M | $40.0M | $32.0M | $24.0M | $24.9M | $46.4M | $67.9M | $54.1M | $2.4M | -$49.4M | $33.4M | -$16.1M | $33.6M | $31.4M | $31.3M | $30.0M | $21.2M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $19.0M | $18.0M | $29.0M | $76.0M | $0.00 | -$3.0M | -$19.0M | -$21.0M | $35.0M | -$57.0M | -$47.0M | -$76.0M | -$9.0M | $0.00 | -$11.0M | $5.0M | $47.0M | -$19.0M | $0.00 | $8.0M | $5.0M | $1.0M | $1.0M | -$6.0M | $0.00 | $0.00 | $1.0M | -$1.0M | $2.0M | $6.0M | $2.0M | -$2.0M | $1.0M | -$657.0K | $422.0K | $704.0K | $1.3M | -$2.5M | $260.0K | $455.0K | $324.0K | $296.0K | -$165.0K | $712.0K | -$117.0K | -$68.0K | -$355.0K | |||||||||
| Revenues | $11.48B | $11.43B | $11.15B | $10.34B | $9.88B | $9.93B | $8.55B | $8.33B | $8.15B | $7.93B | $8.05B | $7.77B | $7.04B | $6.80B | $6.52B | $5.02B | $4.62B | $4.55B | $4.27B | $4.24B | $4.19B | $4.12B | $4.66B | $4.70B | $4.88B | $4.65B | $4.95B | $5.03B | $5.00B | $4.90B | $4.53B | $4.55B | $4.36B | $4.34B | $3.61B | $3.53B | $3.17B | $2.48B | $2.31B | $2.07B | $1.69B | $1.61B | $1.59B | $1.54B | $1.48B | $1.37B | $1.18B | $1.17B | $1.12B | $1.04B | $999.3M | |||||
| Income Tax Expense Benefit | $9.0M | $70.0M | $92.0M | $112.0M | $105.0M | $98.0M | $87.0M | $107.0M | $106.0M | $77.0M | $86.0M | $86.0M | $48.0M | $58.0M | $77.0M | $77.0M | $119.0M | $75.0M | $58.0M | $61.0M | $62.0M | $62.0M | $103.0M | $72.0M | -$16.0M | -$84.0M | $54.0M | $50.0M | $47.0M | $40.0M | $52.0M | $62.0M | $39.0M | $8.4M | $10.7M | $5.7M | $3.9M | $15.5M | $24.4M | -$2.0M | -$21.3M | $11.0M | $10.2M | $10.3M | $10.3M | $9.2M | $6.5M | |||||||||
| General And Administrative Expense | $729.0M | $711.0M | $774.0M | $676.0M | $691.0M | $711.0M | $608.0M | $618.0M | $591.0M | $560.0M | $551.0M | $571.0M | $532.0M | $484.0M | $473.0M | $368.0M | $345.0M | $317.0M | $323.0M | $328.0M | $302.0M | $311.0M | $335.0M | $352.0M | $383.0M | $405.0M | $439.0M | $343.0M | $351.0M | $340.0M | $287.0M | $287.0M | $256.0M | $178.9M | $193.2M | $188.1M | $176.2M | $161.5M | $141.3M | $127.0M | $125.8M | $121.5M | $99.6M | $96.9M | $94.4M | $88.7M | $78.1M | |||||||||
| Comprehensive Income Net Of Tax | $98.0M | $273.0M | $327.0M | $402.0M | $301.0M | $298.0M | $226.0M | $288.0M | $356.0M | $173.0M | $201.0M | $182.0M | $134.0M | $185.0M | $217.0M | $190.0M | $323.0M | $159.0M | $175.0M | $204.0M | $203.0M | $198.0M | $203.0M | $101.0M | -$97.0M | -$230.0M | $78.0M | $41.0M | $35.0M | $30.0M | $48.0M | $37.0M | $29.0M | $15.5M | $8.2M | $5.2M | $8.9M | $22.1M | $30.2M | $3.8M | -$37.0M | $18.4M | $18.8M | $18.2M | $17.3M | $16.1M | $10.2M | |||||||||
| Interest Expense | $27.0M | $27.0M | $27.0M | $28.0M | $28.0M | $27.0M | $28.0M | $30.0M | $30.0M | $30.0M | $27.0M | $24.0M | $21.0M | $22.0M | $22.0M | $23.0M | $26.0M | $32.0M | $33.0M | $32.0M | $27.0M | $26.0M | $26.0M | $25.0M | $25.0M | $15.0M | $15.0M | $15.0M | $14.4M | $14.0M | $13.8M | $13.5M | $11.7M | $13.0M | $4.3M | $3.8M | $4.3M | $4.4M | $3.7M | $3.6M | $4.6M | $4.1M | ||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $25.0M | $23.0M | $39.0M | $100.0M | $1.0M | -$5.0M | -$24.0M | -$29.0M | $46.0M | -$75.0M | -$62.0M | -$100.0M | -$13.0M | $1.0M | -$15.0M | $6.0M | $62.0M | -$25.0M | $0.00 | $10.0M | $7.0M | $1.0M | $1.0M | -$7.0M | $1.0M | $0.00 | $1.0M | -$3.0M | $4.0M | $9.0M | $2.0M | -$3.0M | $2.0M | -$1.1M | $391.0K | $1.4M | $2.1M | -$4.0M | $419.0K | $733.0K | $523.0K | |||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $6.0M | $5.0M | $10.0M | $24.0M | $1.0M | -$2.0M | -$5.0M | -$8.0M | $11.0M | -$18.0M | -$15.0M | -$24.0M | -$4.0M | $1.0M | -$4.0M | $1.0M | $15.0M | -$6.0M | $0.00 | $2.0M | $2.0M | $0.00 | $0.00 | -$1.0M | $1.0M | $0.00 | $0.00 | -$2.0M | $2.0M | $3.0M | $0.00 | -$1.0M | $1.0M | -$404.0K | -$31.0K | $722.0K | $793.0K | -$1.5M | $159.0K | $278.0K | $199.0K | |||||||||||||||
| Health Care Organization Premium Tax Revenue | $506.0M | $431.0M | $388.0M | $508.0M | $298.0M | $297.0M | $176.0M | $169.0M | $172.0M | $223.0M | $215.0M | $208.0M | $204.0M | $185.0M | $187.0M | $170.0M | $157.0M | $150.0M | $119.0M | $110.0M | $138.0M | $110.0M | $106.0M | $104.0M | $106.0M | $114.0M | $111.0M | $127.0M | $109.0M | $109.0M | $99.0M | $95.0M | $95.0M | $81.2M | $70.1M | $51.7M | $43.7M | $46.9M | $37.0M | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $243.0M | $305.0M | $262.0M | $395.0M | $253.0M | $233.0M | $257.0M | $260.0M | $259.0M | $305.0M | $179.0M | -$113.0M | -$314.0M | $131.0M | $92.0M | $80.0M | $64.0M | $98.0M | $101.0M | $67.0M | $24.5M | $18.4M | $10.5M | $11.4M | $31.3M | $55.0M | $50.1M | -$2.1M | -$54.3M | $29.1M | -$20.0M | $29.2M | $27.7M | $27.7M | $25.4M | $17.1M | ||||||||||||||||||||
| Health Care Organization Premium Revenue | $4.32B | $4.78B | $4.74B | $4.65B | $4.18B | $4.19B | $4.03B | $4.00B | $3.59B | $3.38B | $3.30B | $2.97B | $2.60B | $2.32B | $2.17B | $1.94B | $1.60B | $1.58B | $1.50B | $1.50B | $1.48B | $1.45B | $1.39B | $1.23B | $1.25B | $1.14B | $1.13B | $1.08B | $1.01B | $976.7M | ||||||||||||||||||||||||||
| Technology Services Revenue | $134.0M | $130.0M | $129.0M | $131.0M | $131.0M | $133.0M | $135.0M | $140.0M | $107.0M | $47.0M | $47.0M | $52.0M | $54.0M | $52.0M | $50.0M | $54.0M | $54.0M | $51.1M | $49.7M | $49.8M | $55.4M | $48.4M | $41.7M | $42.2M | $49.2M | $37.7M | $36.9M | $36.7M | $32.3M | $21.1M | ||||||||||||||||||||||||||
| Nonoperating Income Expense | -$27.0M | -$27.0M | -$28.0M | -$28.0M | -$27.0M | -$28.0M | -$30.0M | -$30.0M | -$30.0M | -$27.0M | -$29.0M | -$21.0M | -$24.0M | -$8.0M | -$20.0M | -$36.0M | -$37.0M | -$43.0M | -$32.0M | -$27.0M | $49.0M | -$26.0M | -$25.0M | -$25.0M | -$15.2M | -$14.9M | -$14.9M | -$15.3M | -$14.0M | -$13.8M | -$13.5M | -$15.2M | -$12.9M | |||||||||||||||||||||||
| Other Nonoperating Income Expense | $0.00 | $0.00 | $0.00 | -$5.0M | $0.00 | -$2.0M | $14.0M | $3.0M | -$10.0M | -$5.0M | -$10.0M | $0.00 | $0.00 | $75.0M | $0.00 | $0.00 | $0.00 | $40.0K | $32.0K | $10.0K | -$863.0K | $9.0K | $44.0K | $24.0K | -$3.5M | $131.0K | -$4.5M | -$4.9M | -$4.3M | |||||||||||||||||||||||||||
| Health Care Organization Insurer Fee Revenue | $0.00 | $0.00 | $0.00 | $69.0M | $71.0M | $66.0M | $0.00 | $0.00 | $0.00 | $83.0M | $104.0M | $61.0M | $0.00 | $0.00 | $0.00 | $85.0M | $76.0M | $90.0M | $81.0M | $74.0M | $48.0M | $29.4M | $19.7M | $18.7M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||
| Cost Of Goods And Services Sold | $10.04B | $9.83B | $9.48B | $8.64B | $8.37B | $8.41B | $7.31B | $7.04B | $6.87B | $6.75B | $6.87B | $6.56B | $6.05B | $5.82B | $5.47B | $4.10B | $3.60B | $3.72B | $3.52B | $3.47B | $3.37B | |||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | $0.77 | $0.72 | $0.56 | $0.33 | $0.16 | $0.10 | $0.16 | $0.34 | $0.65 | -$0.01 | -$0.71 | |||||||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.84 | $0.78 | $0.58 | $0.34 | $0.17 | $0.11 | $0.17 | $0.35 | $0.66 | -$0.01 | -$0.71 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.07B | $4.50B | $4.22B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | $892.9M | $782.3M | $755.1M | $719.1M | $542.7M |
| Liability For Claims And Claims Adjustment Expense | $4.89B | $4.64B | $4.20B | $3.53B | $3.36B | $2.70B | $1.85B | $1.96B | $2.19B | $1.93B | $1.69B | $1.20B | $670.0M | $495.0M | $402.5M | $354.4M | |
| Cash And Cash Equivalents At Carrying Value | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | $936.0M | $796.0M | $493.8M | $455.9M | $469.5M |
| Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.44B | $2.99B | $1.93B | $1.65B | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.35B | $4.74B | $4.91B | $4.05B | $4.51B | $4.22B | $2.51B | $2.93B | $3.29B | $2.91B | $2.43B | ||||||
| Retained Earnings Accumulated Deficit | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298.0M | $810.0M | $758.0M | $615.0M | $553.1M | $500.2M | $490.4M | ||
| Restricted Investments Noncurrent | $299.0M | $286.0M | $261.0M | $238.0M | $212.0M | $136.0M | $79.0M | $120.0M | $119.0M | $110.0M | $109.0M | $102.0M | $63.1M | $44.1M | $46.2M | ||
| Receivables Net Current | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871.0M | $974.0M | $597.0M | $596.0M | $298.9M | $149.7M | $167.9M | ||
| Other Liabilities Noncurrent | $173.0M | $120.0M | $124.0M | $104.0M | $140.0M | $119.0M | $90.0M | $44.0M | $61.0M | $42.0M | $37.0M | $34.0M | $26.4M | $23.5M | $21.8M | ||
| Other Assets Noncurrent | $147.0M | $138.0M | $143.0M | $123.0M | $179.0M | $119.0M | $105.0M | $24.0M | $141.0M | $41.0M | $28.0M | $30.0M | $46.5M | $19.6M | $17.1M | ||
| Marketable Securities Current | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | $703.1M | $342.8M | $336.9M | ||
| Liabilities Current | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.97B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.18B | $1.29B | $828.0M | $601.8M | ||
| Liabilities And Stockholders Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.44B | $3.00B | $1.93B | $1.65B | ||
| Liabilities | $11.50B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.43B | $2.11B | $1.15B | $897.1M | ||
| Common Stock Value Outstanding | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $46.0K | $47.0K | $46.0K | ||
| Assets Current | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | $2.04B | $1.35B | $1.05B | ||
| Additional Paid In Capital Common Stock | $452.0M | $462.0M | $410.0M | $328.0M | $236.0M | $199.0M | $175.0M | $643.0M | $1.04B | $841.0M | $803.0M | $396.0M | $340.8M | $285.5M | $266.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $15.0M | -$57.0M | -$82.0M | -$160.0M | -$5.0M | $37.0M | $4.0M | -$8.0M | -$5.0M | -$2.0M | -$4.0M | -$1.0M | -$1.1M | -$457.0K | -$1.4M | ||
| Accounts Payable And Accrued Liabilities Current | $1.09B | $1.33B | $1.25B | $889.0M | $842.0M | $641.0M | $502.0M | $390.0M | $366.0M | $385.0M | $362.0M | $242.0M | $263.0M | $184.0M | $147.2M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Other Operating Activities Cash Flow Statement | -$3.0M | $8.0M | $2.0M | $8.0M | $33.0M | $12.0M | $0.00 | $26.0M | $21.0M | $16.0M | $19.0M | $7.0M | $18.0M | $11.2M | |||
| Long Term Debt Noncurrent | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $975.0M | $216.9M | ||||||
| Prepaid Expense And Other Assets Current | $655.0M | $487.0M | $331.0M | $277.0M | $247.0M | $175.0M | $163.0M | $149.0M | $239.0M | $131.0M | $192.0M | $49.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.19B | $4.60B | $4.31B | $4.77B | $4.84B | $4.49B | $3.88B | $3.62B | $3.29B | $3.04B | $2.83B | $2.79B | $2.52B | $2.37B | $2.16B | $2.10B | $2.20B | $2.00B | $1.65B | $1.96B | $1.83B | $1.74B | $1.84B | $1.65B | $1.56B | $1.66B | $1.55B | $1.34B | $1.43B | $1.52B | $1.73B | $1.69B | $1.64B | $1.59B | $1.52B | $1.46B | $1.04B | $964.3M | $917.1M | $897.7M | $892.8M | $876.4M | $764.2M | $755.0M | $746.0M | $775.3M | $781.8M | $765.9M | $719.1M | ||||
| Liability For Claims And Claims Adjustment Expense | $4.84B | $4.89B | $4.80B | $4.73B | $4.58B | $4.57B | $4.24B | $3.68B | $3.82B | $3.62B | $3.78B | $3.60B | $3.19B | $2.94B | $2.84B | $2.29B | $1.96B | $1.98B | $1.98B | $1.77B | $2.00B | $2.04B | $1.92B | $2.02B | $2.48B | $2.08B | $1.93B | $1.87B | $1.77B | $1.94B | $1.56B | $1.49B | $1.45B | $1.12B | $924.2M | $819.5M | $632.7M | $465.5M | $491.1M | $536.5M | $525.5M | $455.8M | $361.1M | $341.6M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $4.22B | $4.50B | $4.86B | $4.73B | $4.35B | $4.51B | $5.57B | $4.91B | $4.55B | $4.24B | $4.31B | $4.80B | $4.36B | $4.61B | $4.43B | $3.20B | $3.30B | $2.37B | $2.68B | $2.25B | $3.22B | $2.81B | $3.40B | $3.73B | $3.93B | $2.98B | $3.20B | $2.84B | $2.35B | $2.16B | $2.16B | $2.01B | $1.87B | $1.60B | $1.03B | $1.08B | $856.6M | $742.7M | $1.17B | $715.5M | $727.1M | $517.7M | $487.5M | $459.2M | $463.8M | $426.5M | $461.0M | ||||||
| Assets | $15.70B | $16.21B | $16.39B | $15.76B | $15.19B | $15.51B | $14.87B | $13.66B | $13.37B | $12.79B | $12.57B | $12.36B | $11.03B | $10.53B | $9.95B | $7.88B | $7.88B | $7.13B | $6.70B | $6.69B | $7.58B | $8.05B | $8.76B | $9.13B | $8.95B | $8.58B | $8.04B | $7.57B | $7.20B | $7.18B | $5.92B | $5.74B | $5.17B | $4.06B | $3.45B | $3.29B | $2.93B | $2.58B | $2.49B | $1.91B | $1.92B | $1.74B | $1.62B | $1.60B | $1.51B | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.32B | $4.59B | $4.96B | $4.88B | $4.42B | $4.57B | $5.62B | $4.96B | $4.60B | $4.30B | $4.38B | $4.87B | $4.44B | $4.68B | $4.50B | $3.27B | $3.37B | $2.42B | $2.73B | $2.33B | $3.30B | $2.91B | $3.50B | $3.82B | $4.03B | $3.07B | $3.29B | ||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | $3.76B | $4.16B | $3.90B | $4.33B | $4.49B | $4.19B | $3.67B | $3.43B | $3.12B | $2.94B | $2.71B | $2.66B | $2.30B | $2.15B | $1.97B | $1.98B | $1.80B | $1.52B | $1.67B | $1.49B | $1.30B | $811.0M | $614.0M | $412.0M | $560.0M | $657.0M | $887.0M | $857.0M | $815.0M | $782.0M | $728.7M | $682.4M | $643.5M | $581.6M | $565.4M | $557.6M | $562.3M | $554.7M | $530.1M | $474.6M | $471.2M | $508.5M | $523.4M | $504.4M | $469.6M | ||||||||
| Restricted Investments Noncurrent | $300.0M | $291.0M | $311.0M | $289.0M | $268.0M | $261.0M | $261.0M | $249.0M | $242.0M | $242.0M | $219.0M | $221.0M | $156.0M | $145.0M | $138.0M | $93.0M | $87.0M | $82.0M | $79.0M | $98.0M | $100.0M | $118.0M | $117.0M | $120.0M | $117.0M | $118.0M | $115.0M | $116.0M | $107.0M | $116.0M | $102.0M | $111.0M | $101.4M | $93.1M | $84.4M | $82.0M | $65.2M | $56.9M | $55.1M | $44.5M | $43.6M | $41.9M | $50.5M | $50.3M | $42.1M | ||||||||
| Receivables Net Current | $3.52B | $3.87B | $3.49B | $3.26B | $3.23B | $3.35B | $2.46B | $2.39B | $2.54B | $2.22B | $2.24B | $2.16B | $1.91B | $1.86B | $1.78B | $1.78B | $1.58B | $1.60B | $1.28B | $1.24B | $1.36B | $1.35B | $1.15B | $950.0M | $1.00B | $1.01B | $1.01B | $1.05B | $1.01B | $863.0M | $619.9M | $631.1M | $491.4M | $425.7M | $473.5M | $338.2M | $294.0M | $213.8M | $150.3M | $156.9M | $161.0M | $222.3M | $180.0M | $172.7M | $168.2M | ||||||||
| Other Liabilities Noncurrent | $174.0M | $167.0M | $155.0M | $122.0M | $122.0M | $124.0M | $121.0M | $122.0M | $88.0M | $118.0M | $126.0M | $134.0M | $95.0M | $101.0M | $112.0M | $85.0M | $84.0M | $87.0M | $90.0M | $93.0M | $97.0M | $60.0M | $68.0M | $59.0M | $48.0M | $54.0M | $44.0M | $39.0M | $38.0M | $38.0M | $32.3M | $31.1M | $33.3M | $28.3M | $28.7M | $27.7M | $25.2M | $23.9M | $23.8M | $22.1M | $22.3M | $22.2M | $17.3M | $20.5M | $19.7M | ||||||||
| Other Assets Noncurrent | $142.0M | $148.0M | $163.0M | $132.0M | $136.0M | $134.0M | $125.0M | $118.0M | $119.0M | $186.0M | $193.0M | $181.0M | $128.0M | $134.0M | $137.0M | $101.0M | $99.0M | $99.0M | $108.0M | $106.0M | $111.0M | $30.0M | $28.0M | $135.0M | $42.0M | $47.0M | $43.0M | $40.0M | $39.0M | $37.0M | $36.6M | $37.8M | $34.1M | $51.1M | $45.7M | $39.7M | $35.7M | $35.8M | $29.4M | $20.1M | $20.4M | $19.8M | $13.9M | $14.8M | $17.4M | ||||||||
| Marketable Securities Current | $4.23B | $4.31B | $4.44B | $4.48B | $4.35B | $4.42B | $4.11B | $3.89B | $3.81B | $3.64B | $3.57B | $2.99B | $2.90B | $2.24B | $1.94B | $1.77B | $1.91B | $2.01B | $1.76B | $2.07B | $1.51B | $1.81B | $2.18B | $2.44B | $1.79B | $2.19B | $2.06B | $1.74B | $1.97B | $2.07B | $1.46B | $1.47B | $1.20B | $842.7M | $740.9M | $696.2M | $735.2M | $718.5M | $341.9M | $356.9M | $344.9M | $358.0M | $324.9M | $356.6M | $295.4M | ||||||||
| Liabilities Current | $7.48B | $7.88B | $8.16B | $8.34B | $7.84B | $8.51B | $8.49B | $7.54B | $7.61B | $7.24B | $7.23B | $7.04B | $6.07B | $5.71B | $5.32B | $3.56B | $3.76B | $3.57B | $3.31B | $3.39B | $4.29B | $5.21B | $5.82B | $6.01B | $5.96B | $5.79B | $4.42B | $4.67B | $3.65B | $4.38B | $3.86B | $3.74B | $3.59B | $1.94B | $1.63B | $1.56B | $1.05B | $707.2M | $803.0M | $831.9M | $839.1M | $677.1M | $604.4M | $608.8M | $565.5M | ||||||||
| Liabilities And Stockholders Equity | $15.70B | $16.21B | $16.39B | $15.76B | $15.19B | $15.51B | $14.87B | $13.66B | $13.37B | $12.79B | $12.57B | $12.36B | $11.03B | $10.53B | $9.95B | $7.88B | $7.88B | $7.13B | $6.70B | $6.69B | $7.58B | $8.05B | $8.76B | $9.13B | $8.95B | $8.58B | $8.04B | $7.57B | $7.20B | $7.18B | $5.92B | $5.74B | $5.17B | $4.06B | $3.45B | $3.29B | $2.93B | $2.58B | $2.49B | $1.91B | $1.92B | $1.74B | $1.62B | $1.60B | $1.51B | ||||||||
| Liabilities | $11.51B | $11.61B | $12.08B | $10.99B | $10.34B | $11.02B | $10.99B | $10.04B | $10.08B | $9.75B | $9.74B | $9.57B | $8.52B | $8.16B | $7.79B | $5.68B | $5.88B | $5.48B | $4.87B | $4.95B | $5.74B | $6.49B | $7.11B | $7.58B | $7.53B | $7.06B | $6.31B | $5.88B | $5.56B | $5.59B | $4.40B | $4.27B | $4.13B | $3.09B | $2.53B | $2.40B | $2.03B | $1.70B | $1.72B | $1.15B | $1.17B | $964.7M | $836.5M | $834.6M | $790.2M | ||||||||
| Common Stock Value Outstanding | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $56.0K | $56.0K | $50.0K | $48.0K | $46.0K | $46.0K | $46.0K | $46.0K | $45.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $45.0K | ||||||||
| Assets Current | $12.55B | $13.11B | $13.26B | $12.88B | $12.33B | $12.67B | $12.47B | $11.44B | $11.16B | $10.49B | $10.33B | $10.15B | $9.37B | $8.87B | $8.31B | $6.95B | $7.06B | $6.32B | $5.88B | $5.86B | $6.73B | $7.30B | $8.03B | $8.20B | $7.71B | $7.17B | $6.40B | $6.11B | $5.55B | $5.76B | $4.91B | $4.81B | $4.28B | $2.99B | $2.37B | $2.28B | $1.97B | $1.74B | $1.73B | $1.31B | $1.32B | $1.15B | $1.03B | $1.03B | $957.9M | ||||||||
| Additional Paid In Capital Common Stock | $420.0M | $454.0M | $434.0M | $453.0M | $439.0M | $390.0M | $373.0M | $341.0M | $296.0M | $289.0M | $251.0M | $218.0M | $205.0M | $191.0M | $170.0M | $181.0M | $166.0M | $140.0M | $160.0M | $240.0M | $543.0M | $760.0M | $1.06B | $1.15B | $870.0M | $865.0M | $841.0M | $831.0M | $822.0M | $806.0M | $789.9M | $782.4M | $398.1M | $383.3M | $351.5M | $340.4M | $332.0M | $324.4M | $234.2M | $280.7M | $275.6M | $267.9M | $260.2M | $263.0M | $251.6M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $9.0M | -$10.0M | -$28.0M | -$9.0M | -$85.0M | -$85.0M | -$165.0M | -$146.0M | -$125.0M | -$185.0M | -$128.0M | -$81.0M | $17.0M | $26.0M | $26.0M | $37.0M | $32.0M | -$15.0M | $5.0M | $5.0M | -$3.0M | -$10.0M | -$11.0M | -$12.0M | -$1.0M | -$1.0M | -$1.0M | $3.0M | $4.0M | $2.0M | -$701.0K | -$1.8M | $297.0K | -$617.0K | $40.0K | -$382.0K | -$1.4M | -$2.7M | -$197.0K | -$330.0K | -$785.0K | -$1.1M | -$1.8M | -$1.6M | -$2.2M | ||||||||
| Accounts Payable And Accrued Liabilities Current | $1.12B | $1.11B | $1.12B | $1.22B | $973.0M | $1.11B | $1.09B | $857.0M | $787.0M | $818.0M | $715.0M | $809.0M | $797.0M | $651.0M | $695.0M | $566.0M | $876.0M | $743.0M | $478.0M | $373.0M | $444.0M | $824.0M | $754.0M | $713.0M | $485.0M | $375.0M | $438.0M | $383.0M | $537.0M | $601.0M | $274.1M | $399.2M | $427.6M | $609.4M | $475.4M | $406.4M | $282.7M | $180.2M | $160.0M | $151.0M | $136.1M | $124.6M | $141.7M | $133.0M | $137.9M | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Other Operating Activities Cash Flow Statement | $2.0M | $2.0M | $5.0M | -$8.0M | $12.0M | -$3.0M | $6.0M | $2.0M | $3.0M | $6.0M | $3.0M | -$1.5M | |||||||||||||||||||||||||||||||||||||||||
| Long Term Debt Noncurrent | $3.66B | $3.38B | $3.57B | $2.33B | $2.18B | $2.18B | $2.18B | $2.18B | $2.18B | $2.18B | $2.18B | $2.17B | $2.13B | $2.13B | $2.13B | $1.81B | $1.81B | $1.60B | $1.24B | $1.24B | $1.12B | $1.02B | $1.02B | $1.32B | $1.32B | $1.02B | $642.0M | $261.8M | $260.6M | $269.3M | $228.2M | $168.1M | $166.7M | $164.0M | |||||||||||||||||||
| Prepaid Expense And Other Assets Current | $590.0M | $438.0M | $472.0M | $408.0M | $399.0M | $381.0M | $332.0M | $260.0M | $259.0M | $391.0M | $213.0M | $198.0M | $197.0M | $168.0M | $163.0M | $213.0M | $273.0M | $346.0M | $140.0M | $132.0M | $124.0M | $486.0M | $344.0M | $411.0M | $174.0M | $159.0M | $142.0M | $169.0M | $197.0M | $260.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $47.0M | $116.0M | $115.0M | $103.0M | $72.0M | $57.0M | $39.0M | $27.0M | $46.0M | $26.0M | $23.0M | $22.0M | $29.0M | $20.0M | $17.1M | $9.5M |
| Depreciation Depletion And Amortization | $195.0M | $186.0M | $171.0M | $176.0M | $131.0M | $88.0M | $89.0M | $127.0M | $178.0M | $182.0M | $126.0M | $134.0M | $94.0M | $78.8M | $74.4M | $60.8M |
| Stock Issued During Period Value Share Based Compensation | $39.0M | $85.0M | $82.0M | $97.0M | $39.0M | $65.0M | $47.0M | $37.0M | $42.0M | $36.0M | $26.0M | $30.0M | $31.0M | $16.4M | $20.5M | $11.3M |
| Proceeds From Sale And Maturity Of Marketable Securities | $1.41B | $1.11B | $772.0M | $1.40B | $1.33B | $1.10B | $2.30B | $2.45B | $1.76B | $1.97B | $1.13B | $633.0M | $400.0M | $298.0M | $302.7M | $223.1M |
| Payments To Acquire Marketable Securities | $751.0M | $1.13B | $1.43B | $1.91B | $2.71B | $670.0M | $2.54B | $1.44B | $2.70B | $1.93B | $1.92B | $953.0M | $770.0M | $306.4M | $346.0M | $302.8M |
| Net Cash Provided By Used In Operating Activities | -$535.0M | $644.0M | $1.66B | $773.0M | $2.12B | $1.90B | $434.0M | -$314.0M | $804.0M | $673.0M | $1.13B | $1.06B | $190.0M | $347.8M | $225.4M | $161.4M |
| Net Cash Provided By Used In Investing Activities | $312.0M | -$464.0M | -$744.0M | -$790.0M | -$1.65B | -$400.0M | -$293.0M | $1.14B | -$1.06B | -$206.0M | -$1.42B | -$536.0M | -$543.0M | -$93.6M | -$236.9M | -$288.8M |
| Net Cash Provided By Used In Financing Activities | -$170.0M | -$347.0M | -$58.0M | -$441.0M | -$183.0M | $217.0M | -$559.0M | -$1.19B | $636.0M | $19.0M | $1.09B | $79.0M | $493.0M | $47.7M | $49.5M | $113.8M |
| Increase Decrease In Receivables | $145.0M | $78.0M | $778.0M | $95.0M | $415.0M | $100.0M | $76.0M | $530.0M | -$103.0M | $348.0M | -$56.0M | $298.0M | $149.0M | -$18.2M | -$352.0K | $7.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$52.0M | $57.0M | $69.0M | $124.0M | $19.0M | $16.0M | -$28.0M | -$6.0M | $56.0M | $69.0M | $35.0M | $20.0M | $23.0M | $9.0M | -$3.3M | $12.0M |
| Increase Decrease In Health Care Insurance Liabilities | -$132.0M | -$40.0M | $580.0M | $153.0M | $471.0M | $544.0M | -$107.0M | -$226.0M | $263.0M | $226.0M | $482.0M | $531.0M | $175.0M | $92.1M | $48.1M | $34.4M |
| Increase Decrease In Accrued Income Taxes Payable | -$201.0M | -$18.0M | -$2.0M | $2.0M | $7.0M | -$14.0M | -$15.0M | $51.0M | -$16.0M | -$26.0M | -$22.0M | $42.0M | -$39.0M | $18.2M | -$24.9M | $19.3M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$221.0M | $115.0M | $328.0M | $55.0M | $138.0M | $86.0M | $9.0M | $45.0M | -$12.0M | -$4.0M | $84.0M | $11.0M | $33.0M | $8.1M | $2.8M | $40.5M |
| Increase Decrease In Deferred Income Taxes | -$43.0M | -$53.0M | $31.0M | $66.0M | $24.0M | $19.0M | -$10.0M | $6.0M | $94.0M | -$22.0M | $7.0M | $2.0M | $32.0M | $9.9M | -$13.8M | $4.1M |
| Proceeds From Payments For Other Financing Activities | $29.0M | -$30.0M | $2.0M | $33.0M | $1.0M | $2.0M | $29.0M | $18.0M | $11.0M | $19.0M | $5.0M | $2.0M | $2.0M | $3.7M | ||
| Payments For Proceeds From Other Investing Activities | -$1.0M | -$1.0M | -$4.0M | $50.0M | $63.0M | -$2.0M | $2.0M | $18.0M | $38.0M | $19.0M | $35.0M | $23.0M | -$6.0M | |||
| Payments To Acquire Businesses Net Of Cash Acquired | $245.0M | $344.0M | $3.0M | $134.0M | $129.0M | $755.0M | $0.00 | $0.00 | $0.00 | $48.0M | $450.0M | $44.0M | $62.0M | $0.00 | $84.3M | $130.7M |
| Payments To Acquire Property Plant And Equipment | $101.0M | $100.0M | $84.0M | $91.0M | $77.0M | $74.0M | $57.0M | $30.0M | $86.0M | $176.0M | $132.0M | $115.0M | ||||
| Payments For Repurchase Of Common Stock | $1.00B | $1.00B | $0.00 | $400.0M | $128.0M | $606.0M | $47.0M | $0.00 | $0.00 | $0.00 | $0.00 | $53.0M | $3.0M | $7.0M | $0.00 | |
| Increase Decrease In Medical Premium Liability Due To Agency | -$591.0M | -$453.0M | $196.0M | -$428.0M | $1.05B | $446.0M | -$303.0M | -$574.0M | $341.0M | $473.0M | $202.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $27.0M | $36.0M | $25.0M | $34.0M | $24.0M | $15.0M | $16.0M | $12.0M | $10.0M | $10.0M | $9.0M | $7.0M | $7.0M | $6.0M | $3.0M | $6.0M | $7.0M | $6.0M | $5.6M | $4.4M | $4.7M | $4.1M | |||||||||||||||||
| Depreciation Depletion And Amortization | $48.0M | $45.0M | $44.0M | $40.0M | $33.0M | $20.0M | $25.0M | $37.0M | $49.0M | $44.0M | $33.0M | $33.0M | $24.1M | $22.1M | $21.8M | $20.3M | $19.7M | $18.3M | $17.8M | $16.5M | $18.1M | ||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | -$5.0M | $20.0M | -$8.0M | $28.0M | $49.0M | -$20.0M | $32.0M | $45.0M | -$32.0M | $38.0M | $35.0M | -$18.0M | $14.0M | $21.0M | -$27.0M | $15.0M | $26.0M | $4.0M | $10.0M | $18.0M | $3.0M | $7.0M | $15.0M | $1.0M | $5.0M | $24.0M | |||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $331.0M | $211.0M | $371.0M | $513.0M | $308.0M | $493.0M | $366.0M | $543.0M | $433.0M | $348.0M | $255.0M | $147.4M | $75.6M | $65.8M | $61.3M | ||||||||||||||||||||||||
| Payments To Acquire Marketable Securities | $189.0M | $380.0M | $646.0M | $403.0M | $388.0M | $578.0M | $185.0M | $389.0M | $733.0M | $611.0M | $438.0M | $142.1M | $76.0M | $88.2M | $105.0M | ||||||||||||||||||||||||
| Net Cash Provided By Used In Operating Activities | $190.0M | $214.0M | $916.0M | $363.0M | $568.0M | $143.0M | $249.0M | $394.0M | $719.0M | $139.0M | $554.0M | $210.9M | $20.1M | $50.6M | $84.1M | ||||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$123.0M | -$488.0M | -$302.0M | $74.0M | -$87.0M | -$103.0M | $171.0M | $145.0M | -$337.0M | -$314.0M | -$228.0M | -$27.5M | -$21.2M | -$42.7M | -$79.8M | ||||||||||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $147.0M | -$62.0M | -$65.0M | -$77.0M | -$207.0M | -$125.0M | -$48.0M | -$5.0M | -$1.0M | $2.0M | $5.0M | -$35.9M | $374.8M | $16.0M | $3.5M | ||||||||||||||||||||||||
| Increase Decrease In Receivables | $90.0M | $123.0M | $234.0M | -$21.0M | $98.0M | $197.0M | $29.0M | $83.0M | $32.0M | $266.0M | -$105.0M | $39.3M | $569.0K | $54.4M | -$19.4M | ||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $56.0M | -$8.0M | -$7.0M | $32.0M | $15.0M | $229.0M | -$20.0M | $239.0M | $12.0M | $202.0M | $137.0M | $78.0M | $9.0M | $5.6M | $8.1M | ||||||||||||||||||||||||
| Increase Decrease In Health Care Insurance Liabilities | -$81.0M | -$24.0M | $296.0M | $263.0M | $168.0M | $127.0M | $34.0M | -$163.0M | -$3.0M | $255.0M | $248.0M | $149.8M | -$3.4M | $53.4M | -$3.0M | ||||||||||||||||||||||||
| Increase Decrease In Accrued Income Taxes Payable | $77.0M | $65.0M | $101.0M | $67.0M | $66.0M | $60.0M | $43.0M | $78.0M | $59.0M | -$24.0M | $2.0M | $4.6M | $8.4M | -$3.7M | -$5.4M | ||||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$268.0M | -$215.0M | -$215.0M | -$81.0M | $16.0M | $254.0M | -$30.0M | $319.0M | $50.0M | $205.0M | $189.0M | $59.0M | -$31.8M | -$34.8M | -$25.8M | ||||||||||||||||||||||||
| Increase Decrease In Deferred Income Taxes | -$13.0M | -$26.0M | -$1.0M | -$16.0M | -$6.0M | -$14.0M | -$15.0M | $6.0M | $5.0M | -$30.0M | -$1.0M | $670.0K | $16.0K | -$8.3M | -$1.6M | ||||||||||||||||||||||||
| Proceeds From Payments For Other Financing Activities | $33.0M | -$6.0M | -$7.0M | -$5.0M | -$8.0M | -$45.0M | $1.0M | -$5.0M | -$2.0M | $2.0M | $4.0M | $857.0K | $0.00 | ||||||||||||||||||||||||||
| Payments For Proceeds From Other Investing Activities | -$2.0M | -$3.0M | -$5.0M | $13.0M | -$9.0M | -$3.0M | $4.0M | $5.0M | $6.0M | -$1.0M | $7.0M | $547.0K | |||||||||||||||||||||||||||
| Payments To Acquire Businesses Net Of Cash Acquired | $245.0M | $295.0M | $0.00 | $0.00 | $2.0M | $8.0M | $0.00 | $0.00 | $3.3M | ||||||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $22.0M | $27.0M | $32.0M | $23.0M | $16.0M | $21.0M | $6.0M | $4.0M | $26.0M | $46.0M | |||||||||||||||||||||||||||||
| Payments For Repurchase Of Common Stock | $500.0M | $0.00 | $0.00 | $128.0M | $453.0M | $0.00 | $0.00 | $50.0M | $50.0M | $50.0M | $0.00 | ||||||||||||||||||||||||||||
| Increase Decrease In Medical Premium Liability Due To Agency | -$32.0M | $183.0M | $270.0M | $137.0M | $432.0M | $113.0M | -$35.0M | $172.0M | $373.0M | $181.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | $1.13 | $0.21 | $0.45 | $1.32 |
| Earnings Per Share Basic | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | $1.16 | $0.21 | $0.45 | $1.34 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 80.0M | ||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 51.0M | 56.0M | 58.0M | 58.0M | 58.0M | 62.0M | 62.0M | 60.0M | 57.0M | 56.0M | 50.0M | 45.9M | 46.8M | 45.8M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 52.8M | 57.4M | 57.7M | 57.8M | 57.8M | 59.0M | 62.2M | 61.1M | 56.4M | 55.4M | 52.0M | 47.0M | 46.0M | 46.4M | 45.8M | 41.2K |
| Weighted Average Number Of Diluted Shares Outstanding | 52.9M | 57.7M | 58.1M | 58.5M | 58.6M | 59.9M | 64.2M | 66.6M | 56.4M | 56.2M | 56.0M | 48.0M | 47.0M | 47.0M | 46.4M | 41.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $1.51 | $4.75 | $5.45 | $5.65 | $5.17 | $5.17 | $4.21 | $5.35 | $5.52 | $3.95 | $4.25 | $4.39 | $2.46 | $3.16 | $3.89 | $3.10 | $4.65 | $2.92 | $2.67 | $2.75 | $3.06 | $2.99 | $3.01 | $2.90 | $3.02 | $1.64 | $-4.59 | $-1.70 | $-4.10 | $1.37 | $-0.85 | $0.76 | $0.58 | $0.43 | $0.52 | $0.77 | $0.72 | $0.56 | $0.69 | $0.33 | $0.16 | $0.09 | $-0.20 | $0.16 | $0.53 | $0.64 | $0.54 | $0.07 | $-0.80 | $0.39 | $-720.00 | $0.41 | $0.38 | $0.38 | $0.38 | $0.27 | ||
| Earnings Per Share Basic | $1.51 | $4.75 | $5.47 | $5.67 | $5.18 | $5.21 | $4.24 | $5.37 | $5.58 | $4.00 | $4.29 | $4.45 | $2.49 | $3.20 | $3.95 | $3.14 | $4.72 | $2.95 | $2.70 | $2.81 | $3.15 | $3.19 | $3.24 | $3.22 | $3.29 | $1.79 | $-4.59 | $-1.70 | $-4.10 | $1.38 | $-0.85 | $0.77 | $0.58 | $0.44 | $0.54 | $0.84 | $0.78 | $0.58 | $0.70 | $0.34 | $0.17 | $0.10 | $-0.20 | $0.17 | $0.54 | $0.65 | $0.55 | $0.07 | $-0.80 | $0.39 | $-0.72 | $0.41 | $0.38 | $0.38 | $0.38 | $0.27 | ||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0K | 80.0M | ||||||||||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0K | 20.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Common Stock Shares Outstanding | 51.0M | 54.0M | 54.0M | 57.0M | 59.0M | 59.0M | 58.0M | 58.0M | 58.0M | 58.0M | 58.0M | 59.0M | 58.0M | 58.0M | 58.0M | 59.0M | 59.0M | 59.0M | 59.0M | 63.0M | 63.0M | 63.0M | 62.0M | 62.0M | 62.0M | 57.0M | 57.0M | 57.0M | 57.0M | 57.0M | 57.0M | 56.1M | 56.1M | 49.9M | 48.3M | 46.5M | 46.3M | 45.8M | 45.7M | 45.4M | 46.6M | 46.5M | 46.3M | 45.7M | 46.1K | 45.5M | ||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 45.7M | 45.4M | 46.0M | 46.5M | 46.4M | 46.0M | 45.8M | 45.9M | 45.6M | 42.2M | 38.6M | |||||||||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 47.1M | 46.5M | 46.4M | 46.9M | 46.4M | 46.9M | 46.3M | 46.5M | 46.3M | 42.5M | 38.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium Tax Expenses | $1.86B | $1.49B | $1.07B | $873.0M | $787.0M | $649.0M | $489.0M | $417.0M | $438.0M | $468.0M | $397.0M | $294.0M | $172.0M | $159.0M | $154.6M | $139.8M |
| Depreciation And Amortization | $195.0M | $186.0M | $171.0M | $176.0M | $131.0M | $88.0M | $89.0M | $99.0M | $137.0M | $139.0M | $104.0M | $93.0M | $73.0M | $63.1M | $48.3M | $45.7M |
| Costs And Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.35B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | $6.45B | $5.87B | $4.40B | $3.98B |
| Interest And Dividend Income Operating | $75.0M | $77.0M | $17.0M | $17.0M | $125.0M | $70.0M | $38.0M | $23.0M | $20.0M | $7.0M | $5.1M | $5.4M | $6.3M | |||
| Health Care Organization Insurer Fee Expense | $0.00 | $0.00 | $277.0M | $0.00 | $348.0M | $0.00 | $217.0M | $157.0M | $89.0M | $0.00 | $0.00 | |||||
| Policyholder Benefits And Claims Incurred Health Care | $17.07B | $14.77B | $11.79B | $8.08B | $5.38B | $4.99B | $3.66B | $3.37B | ||||||||
| Technology Services Costs | $492.0M | $485.0M | $193.0M | $157.0M | $161.0M | $141.2M | $144.0M | $78.6M | ||||||||
| Premiums Earned Net | $43.05B | $38.63B | $32.53B | $30.88B | $26.86B | $18.30B | $16.21B | $17.61B | $18.85B | $16.45B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium Tax Expenses | $506.0M | $431.0M | $388.0M | $508.0M | $298.0M | $297.0M | $176.0M | $169.0M | $172.0M | $223.0M | $215.0M | $208.0M | $204.0M | $185.0M | $187.0M | $170.0M | $157.0M | $150.0M | $119.0M | $110.0M | $138.0M | $110.0M | $106.0M | $104.0M | $106.0M | $114.0M | $111.0M | $127.0M | $109.0M | $109.0M | $99.0M | $95.0M | $95.0M | $81.2M | $70.1M | $51.7M | $43.7M | $46.9M | $37.0M | $37.9M | $38.4M | $42.2M | $36.4M | $37.7M | $36.6M | $35.0M | $35.0M |
| Depreciation And Amortization | $45.0M | $58.0M | $48.0M | $47.0M | $46.0M | $45.0M | $42.0M | $42.0M | $44.0M | $45.0M | $44.0M | $40.0M | $32.0M | $31.0M | $33.0M | $23.0M | $21.0M | $20.0M | $21.0M | $22.0M | $25.0M | $25.0M | $25.0M | $26.0M | $33.0M | $37.0M | $39.0M | $36.0M | $34.0M | $32.0M | $26.0M | $25.0M | $25.0M | $24.2M | $22.9M | $20.7M | $18.9M | $17.0M | $16.6M | $15.9M | $16.2M | $15.0M | $13.4M | $12.5M | $12.7M | $12.0M | $11.2M |
| Costs And Expenses | $11.34B | $11.05B | $10.71B | $9.87B | $9.45B | $9.51B | $8.19B | $7.88B | $7.69B | $7.59B | $7.69B | $7.40B | $6.82B | $6.53B | $6.19B | $4.73B | $4.19B | $4.28B | $3.99B | $3.93B | $3.84B | $4.44B | $4.54B | $4.42B | $5.11B | $5.29B | $4.82B | $4.43B | $4.25B | $4.25B | $3.50B | $3.41B | $3.09B | $2.44B | $2.28B | $2.04B | $1.66B | $1.56B | $1.52B | $1.54B | $1.53B | $1.34B | $1.14B | $1.14B | $1.09B | $1.01B | $978.2M |
| Interest And Dividend Income Operating | $20.0M | $21.0M | $22.0M | $20.0M | $19.0M | $21.0M | $19.0M | $18.0M | $20.0M | $16.0M | $22.0M | $20.0M | $4.0M | $5.0M | $4.0M | $40.0M | $34.0M | $29.0M | $37.0M | $32.0M | $24.0M | $18.0M | $16.0M | $14.0M | $10.0M | $10.0M | $9.0M | $5.0M | $4.0M | $3.0M | $2.0M | $1.9M | $1.6M | $1.7M | $1.6M | $1.5M | $1.2M | $1.1M | $1.7M | $764.0K | $1.4M | $1.6M | $1.8M | $1.6M | |||
| Health Care Organization Insurer Fee Expense | $0.00 | $0.00 | $0.00 | $70.0M | $71.0M | $68.0M | $0.00 | $0.00 | $0.00 | $87.0M | $99.0M | $75.0M | $0.00 | $0.00 | $0.00 | $55.0M | $50.0M | $58.0M | $36.0M | $40.0M | $41.0M | $22.3M | $21.9M | $22.2M | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Policyholder Benefits And Claims Incurred Health Care | $3.72B | $4.22B | $4.49B | $4.11B | $3.75B | $3.59B | $3.59B | $3.02B | $2.93B | $2.64B | $2.10B | $1.93B | $1.72B | $1.38B | $1.29B | $1.29B | $1.32B | $1.32B | $1.13B | $959.2M | $949.4M | $913.5M | $845.9M | $839.6M | |||||||||||||||||||||||
| Technology Services Costs | $120.0M | $123.0M | $124.0M | $122.0M | $119.0M | $116.0M | $127.0M | $34.0M | $33.0M | $36.0M | $40.1M | $37.1M | $40.7M | $40.1M | $39.3M | $39.8M | $37.0M | $30.6M | $30.5M | $34.6M | $39.2M | $31.2M | $27.6M | $14.3M | |||||||||||||||||||||||
| Premiums Earned Net | $10.84B | $10.87B | $10.63B | $9.69B | $9.45B | $9.50B | $8.24B | $8.04B | $7.89B | $7.64B | $7.80B | $7.53B | $6.80B | $6.58B | $6.31B | $4.77B | $4.37B | $4.30B | $4.08B | $4.05B | $3.95B | $4.34B | $4.51B | $4.32B | $4.78B |
Most recent annual filing with the SEC: February 10, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.